SCHEMBL20818000

SCHEMBL20818000

[2H]c1nc2c(n1Cc1ccccc1C(F)(F)F)CCNC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPC5 Q9UL62 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ HTR2C P28335 1/20 0.37
▸ HTR2B P41595 1/20 0.37
▸ KMT2A Q03164 1/20 0.36
▸ MKNK1 Q9BUB5 1/20 0.36
▸ MKNK2 Q9HBH9 1/20 0.36
▸ SLC6A2 P23975 2/20 0.36
▸ SLC6A4 P31645 2/20 0.36
▸ YTHDC1 Q96MU7 1/20 0.35
▸ P2RX7 Q99572 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20817928 0.88 TRPC5 (0.51) TRPC5TDP1ALDH1A1KDM4EATM
SCHEMBL20818900 0.76 TDP1 (0.42) TRPC5TDP1ALDH1A1KDM4EATM
SCHEMBL20818480 0.76 TRPC5 (0.40) TRPC5TDP1ALDH1A1KDM4EATM
SCHEMBL20817991 0.75 TDP1 (0.41) TDP1ALDH1A1KDM4EATMPOLB
SCHEMBL20817900 0.75 P2RX7 (0.43) TRPC5TDP1ALDH1A1KDM4EATM
SCHEMBL20831789 0.73 TDP1 (0.39) TDP1ALDH1A1KDM4EATMPOLB
SCHEMBL28705759 0.72 FABP3 (0.45) TDP1ALDH1A1KDM4EATMKMT2A
SCHEMBL20831855 0.72 TDP1 (0.39) TRPC5TDP1ALDH1A1KDM4EATM
SCHEMBL31574268 0.71 SCD (0.43) TDP1ALDH1A1KDM4EATMKMT2A
SCHEMBL20818468 0.71 NPSR1 (0.44) TDP1ALDH1A1KDM4EATMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12435078-B2 Pyridazinones and methods of use thereof GFB (ABC), LLC (US) 2025-10-07 — — US disclosed
US-20230203028-A1 PYRIDAZINONES AND METHODS OF USE THEREOF GFB (ABC), LLC 2023-06-29 — — US disclosed
EP-3684364-A2 PYRIDAZINONES AND METHODS OF USE THEREOF Goldfinch Bio, Inc. (US) 2020-07-29 — — EP disclosed
WO-2019055966-A2 PYRIDAZINONES AND METHODS OF USE THEREOF GOLDFINCH BIO, INC. (US) 2019-03-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203028-A1 PYRIDAZINONES AND METHODS OF USE THEREOF PDXK, ATP6V1B1, REN TRPC5 1439/4885TDP1 1811/4885ALDH1A1 649/4885
US-12435078-B2 Pyridazinones and methods of use thereof PDXK, ATP6V1B1, REN TRPC5 1439/4885TDP1 1811/4885ALDH1A1 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback